Cargando…

1425. Impact of Social Determinants on Racial Differences in Carbapenem-Resistant Enterobacteriaceae Incidence, Atlanta, 2012-2018

BACKGROUND: Public health prioritizes addressing social determinants of health to promote health equity. We hypothesized that social determinants of health, including poverty, are associated with racial disparity in the incidence of carbapenem-resistant Enterobacteriaceae (CRE). METHODS: The Georgia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Gillian, Bower, Chris W, Fridkin, Scott, Jacob, Jesse T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777505/ http://dx.doi.org/10.1093/ofid/ofaa439.1607

Ejemplares similares

834. Clinical Outcomes with Carbapenem-Resistant Pseudomonas aeruginosa that Retain Susceptibility to Traditional Antipseudomonal β-lactams: Atlanta, 2016-2018
por: Howard-Anderson, Jessica, et al.
Publicado: (2020)

504. Epidemiology of End-stage Renal Disease (ESRD) Patients with Carbapenem-Resistant Enterobacteriaceae (CRE) Infections: Atlanta Metropolitan Area, 2012–2017
por: Hurd, Jacqueline M, et al.
Publicado: (2019)

787. Clinical and Genomic Epidemiology of mcr-9 Containing Carbapenem-resistant Enterobacterales Isolates in Metropolitan Atlanta, 2012-2017
por: Babiker, Ahmed, et al.
Publicado: (2021)

Comparison of 30- and 90-Day Mortality Rates in Patients with Cultures Positive for Carbapenem-resistant Enterobacteriaceae and Acinetobacter in Atlanta, 2011–2015
por: Sexton, Mary Elizabeth, et al.
Publicado: (2017)

506. Urinary Catheters Are Associated with Progression from Bacteriuria to Invasive Infections in Patients with Carbapenem-Resistant Enterobacteriaceae, Metropolitan Atlanta, 2011–2017
por: Howard-Anderson, Jessica, et al.
Publicado: (2019)

Clinical and Genomic Epidemiology of mcr-9-Carrying Carbapenem-Resistant Enterobacterales Isolates in Metropolitan Atlanta, 2012 to 2017
por: Babiker, Ahmed, et al.
Publicado: (2022)

Wide Range of Carbapenem-resistant Enterobacteriaceae Incidence and Trends in Emerging Infections Program Surveillance, 2012–2015
por: Duffy, Nadezhda, et al.
Publicado: (2017)

416. Evaluating Indwelling Devices and Mortality in Invasive Carbapenem-Resistant Enterobacterales Infections, Atlanta, GA, 2012–2019.
por: Witt, Lucy S, et al.
Publicado: (2022)

1425. "Influence of outpatient antibiotic prescriptions in prevalence of ESBL producing Enterobacteriaceae in local hospitals"
por: Ponce, Rafael, et al.
Publicado: (2023)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

P1425: SYSTEMATIC INVESTIGATION OF HYDROXYUREA TREATMENT EFFECT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
por: Bhat, Varsha, et al.
Publicado: (2023)

Carbapenemase genes and mortality in patients with carbapenem-resistant Enterobacterales, Atlanta, Georgia, 2011–2020
por: Witt, Lucy, et al.
Publicado: (2023)

Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999–2012
por: Logan, Latania K., et al.
Publicado: (2015)

1219. Unfavorable Clinical Outcomes with Polymyxins Compared to Ceftolozane/Tazobactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa
por: Howard-Anderson, Jessica, et al.
Publicado: (2021)

Risk factor for mortality associated with carbapenem-resistant Enterobacteriacea infections
por: Carrilho, Cláudia MDM, et al.
Publicado: (2013)

1457. Serial Passage of Enterobacteriaceae to Explore Development of Carbapenem Resistance
por: Nissim, Yosef, et al.
Publicado: (2020)

3167 Evaluation of risk factors for progression from carbapenem-resistant Enterobacteriaceae bacteriuria to an invasive infection
por: Howard-Anderson, Jessica, et al.
Publicado: (2019)

Identifying patients at high risk for carbapenem-resistant Enterobacterales carriage upon admission to acute-care hospitals
por: Howard-Anderson, Jessica, et al.
Publicado: (2023)

Evidence for an N* Resonance at 1425 MeV
por: Adelman, S L
Publicado: (1964)

P1510: INCIDENCE AND RISK FACTORS OF ACTIVE CARBAPENEM-RESISTANT ENTEROBACTERIACEAE SURVEILLANCE FOR PATIENTS ADMITTED TO HEMATOLOGY DEPARTMENT: A PROPENSITY SCORE MATCHING STUDY.
por: Chen, Shaozhen, et al.
Publicado: (2023)

1441. Using Carbapenem Resistance Levels to Discriminate Between Carbapenemase Producing and Non-Carbapenemase Producing Carbapenem Resistant Enterobacteriaceae
por: Koehne, William J, et al.
Publicado: (2020)

Clarifications about the E(1425) meson quantum numbers
por: Baillon, Paul
Publicado: (1982)

Ambiphilic boron in 1,4,2,5-diazadiborinine
por: Wang, Baolin, et al.
Publicado: (2016)

P1425: ACTIVATED AND EXPANDED NATURAL KILLER CELLS TRANSDUCED WITH AN NKG2D CHIMERIC ANTIGEN RECEPTOR AGAINST ACUTE MYELOID LEUKEMIA
por: Córdoba, L., et al.
Publicado: (2022)

1234. Racial Disparities in Invasive Staphylococcus aureus (iSA) Disease in Metropolitan Atlanta, a Population-Based Assessment, 2016
por: Overton, Rahsaan, et al.
Publicado: (2018)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

Utility of Xpert Carba-R® in diagnostic laboratory for early detection of carbapenems resistant Enterobacteriaceae
por: Aljohani, S, et al.
Publicado: (2015)

1618. Meropenem-vaborbactam vs standard of care for multidrug resistant carbapenem-resistant Enterobacteriaceae
por: Misikir, Helina, et al.
Publicado: (2020)

1425. Revisiting β-Lactams for Treatment of Uncomplicated Urinary Tract Infections: Evaluation of Twice-daily Cephalexin for Empiric Treatment of UTIs
por: Benning, Molly, et al.
Publicado: (2021)

513. Transmission of Carbapenem-Resistant Enterobacteriaceae in a Community-Based, Residential Care Setting: Nevada, 2018
por: Gomes, Danica, et al.
Publicado: (2019)

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
por: Ansari, Uzma, et al.
Publicado: (2017)

631. Laboratory Surveillance of Carbapenem-Resistant Enterobacteriaceae in an Endemic Country, Greece, 2015–2018
por: Tryfinopoulou, Kyriaki, et al.
Publicado: (2019)

Study of Traffic incidents with much injured in Kermanshah province from 2012 to 2018
por: Mohamadyari, Touraj, et al.
Publicado: (2019)

843. Increased Carbapenemase Testing Following Implementation of VA Guidelines for Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Fitzpatrick, Margaret A, et al.
Publicado: (2020)

1432. Population-based Surveillance of Carbapenem-Resistant Enterobacteriaceae (CRE) in Alameda County, 2017-2020
por: Horwich-Scholefield, Sam, et al.
Publicado: (2020)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Mortality in patients with carbapenem-resistant Pseudomonas aeruginosa with and without susceptibility to traditional antipseudomonal β-lactams
por: Howard-Anderson, Jessica, et al.
Publicado: (2021)

P075: Emergence of carbapenem-resistant enterobacteriaceae in surgical and intensive care units of a hospital with low usage of carbapenem in Kano, North West Nigeria
por: Yusuf, I, et al.
Publicado: (2013)

Epidemiology of Carbapenem-Resistant Enterobacteriaceae Bacteremia in Gyeonggi Province, Republic of Korea, between 2018 and 2021
por: Lee, Seung Hye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_49b2f4dfrjpu4sg7ulve1mjeg0